Aug 26, 2015, 13:35 PM by Michael Croft

Los Angeles Times | Jeb Bush's presidential run has brought renewed attention to one of the headline achievements of his tenure as governor of Florida: luring a new Scripps Research Institute campus to the state.

Aug 25, 2015, 14:15 PM by Michael Croft

Aug 25, 2015, 14:00 PM by Michael Croft

Aug 21, 2015, 09:56 AM by Michael Croft

PRINCETON, NJ - Aug 20, 2015 - Certara®, the global biosimulation technology-enabled drug development company, today announced that Lawrence J

Aug 21, 2015, 09:10 AM by Michael Croft

Bio-IT World | The idea is beautiful: read the text of DNA and understand the workings of the body. Brendan Frey isn’t claiming it’s simple, but with advanced machine learning and expertise in cell and genome biology, Deep Genomics is chasing the vision. And it might just change everything.

Aug 19, 2015, 12:28 PM by Michael Croft

PHOENIX, AZ, UNITED STATES - Aug 19, 2015 - Ashion Analytics, a CLIA certified and CAP-accredited molecular cancer testing laboratory, today announced its launch and the availability of its flagship product, the Genomic Enabled Medicine (GEM) Cancer Panel™ , to assist doctors in treating patients with cancer

Aug 19, 2015, 09:25 AM by Michael Croft

Aug 18, 2015, 17:29 PM by Michael Croft

MIDDLETON, WI, UNITED STATES - Aug 18, 2015 - PFS Clinical, which offers turnkey administration solutions that address the key pain points of establishing and running a clinical trial office, has been engaged by the Boston Medical Center (BMC) Clinical Trial Office to provide Medicare Coverage Analysis (CA) of its clinical research trials

Aug 18, 2015, 09:00 AM by Michael Croft

New York Times | Helix--a new genomics analytics venture--is to launch today with $100 million in funding from Illumina, Warburg Pincus, and Sutter Hill Ventures. Illumina's Jay Flatley will serve as chairman.

Aug 17, 2015, 13:25 PM by Michael Croft

SOUTH SAN FRANCISCO, CA, UNITED STATES - Aug 17, 2015 - Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today announced the appointment of Neil M

Aug 17, 2015, 11:35 AM by Michael Croft

RESEARCH TRIANGLE PARK, NC - Aug 17, 2015 - Cloud Pharmaceuticals, Inc., a therapeutics company focused on cloud-based drug design and development, today announced the appointment of two C-level executives to its management team

Aug 14, 2015, 12:15 PM by Michael Croft

Bio-IT World | Deep-seated concerns about privacy and security, combined with a tangled variety of data structures and perverse incentives to hoard genomic data, have hindered the ability and willingness of research groups to share DNA data with one another for more open and collaborative science. As a flagship effort of the Global Alliance for Genomics and Health, the Beacon Project is toying with a single, simple query that is forming the basis for more exchange of data across institutional borders.

Aug 14, 2015, 10:31 AM by Michael Croft

Aug 11, 2015, 11:20 AM by Michael Croft

Aug 10, 2015, 16:18 PM by Michael Croft

PRINCETON, NJ - Aug 10, 2015 - Certara®, the global biosimulation technology-enabled drug development company, today announced that Iain Gardner, Ph

Aug 10, 2015, 15:15 PM by Michael Croft

Bio-IT World | CRISPR therapy company Editas has more than doubled its financing with a $120 million funding round announced this morning, led by the newly-formed investment fund bng0.

Aug 10, 2015, 11:00 AM by Michael Croft

FierceBiotech | Illumina has struck a deal to acquire laboratory information management system provider GenoLogics, already a partner creating dedicated LIMS for Illumina's high-throughput sequencers.

Aug 7, 2015, 10:55 AM by Michael Croft

Nature News | As the National Cancer Institute prepares to distribute its second round of five-year grants to Physical Sciences-Oncology Centers, Nature News speaks to scientists who feel a program designed to reinvigorate cancer research with fundamental physical discoveries is missing the mark.

Aug 6, 2015, 11:50 AM by Michael Croft

Bio-IT World | In 2004, the International Glossina Genome Initiative set out to sequence the genome of the tsetse fly, Glossina morsitans, Africa's most unique public health threat. Though the project took over a decade to complete, its legacy is a model for building local capacity for cutting-edge science in African institutions.

Aug 6, 2015, 08:00 AM by Michael Croft

Bio-IT World News Brief | Diagnostics based on next-generation sequencing have forced the FDA to bend some of its standards for proving the analytical and clinical value of new medical tests before they come to market — and a new online platform built with DNAnexus, called precisionFDA, will now formalize and refine some of the new approaches the agency has taken to deal with computational pipelines in genomics.